Susan Hasty, Publisher
Table of Contents . . . October 17th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Gene Delivery - Nonhuman primate adeno-associated viruses considered for human therapies
Melanoma - Novel design enhances GM-CSF tumor vaccine
Cardiovascular Therapy - Lentiviral vectors can transduce human heart cells
Cisplatin - Therapy prevents neuropathic effects of cisplatin chemotherapy
Muscular Dystrophy - Gene therapy reverses muscle wasting in animal model
Thalassemia - Researchers engineer virus that blocks common genetic defect
Adenovirus Vectors - Thixotropic solutions enhance viral-mediated gene transfer to airway epithelia
Antisense Technology - Lipid-mediated delivery of oligonucleotide to pulmonary endothelium developed
Appointments - David W. Robinson named vice president of marketing, sales
Appointments - Rubicon Genomics names Fred G. Beyerlein president and CEO
Bacterial Infections - Pyrosequencing secures access to intellectual property for bacterial identification
Biological Weapons - UT Southwestern researchers develop vaccine against ricin
Cancer Gene Therapy - Carboplatin plus low-dose antisense oligonucleotides slows tumor growth
Cancer Gene Therapy - High-affinity binding by locked nucleic acids inhibits telomerase
Cancer Gene Therapy - Researchers tackle brain tumor chemoresistance
Gene Transfer - Mechanics of angiogenic gene therapy make outcome interpretation difficult
Mergers and Aquisitions - Sequenom acquires Axiom
Oral Vaccines - Microscience now able to deliver DNA vaccines orally
Prostate Cancer - p21 Modulates apoptosis limit induced by dna damage, growth factor withdrawal
Reproductive Medicine - Data reported on long-acting FSH preparation
Restenosis - Gene therapy promising for preventing artery renarrowing
Stem Cell Research - NIH grant received for stem cell-based predictive assays
Vector Development - Pseudorabies virus may have potential as gene vector and oncolytic agent
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.